ViiV Healthcare Company;Janssen Sciences Ireland Unlimited Company
发明人:
Herta CRAUWELS,David MARGOLIS,William R. SPREEN,Andrew SPALTENSTEIN,Peter WILLIAMS
申请号：
US16631868
公开号：
US20200147079A1
申请日:
2018.07.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
